Alan Bradley

Alan Bradley

Fundador en
Kymab Group Ltd.
.
66 años
Health Technology
Consumer Services
Finance

Perfil

Allan Bradley is the founder of Spectral Genomics, Inc., founded in 2000.
Dr. Bradley is the founder of ExpressionEdits Ltd., founded in 2021.
Dr. Bradley is the founder of T-Therapeutics Ltd., founded in 2022, and holds the title Chief Scientific Officer & Director since 2025.
Dr. Bradley is also the founder of Lexicon Pharmaceuticals, Inc.,Kymab Group Ltd...
Dr. Bradley is an Independent Director at Sieger Healthcare Acquisition Corp.
Dr. Bradley is a Professor at the University of Cambridge.
Dr. Bradley was Executive Director at Wellcome Trust Sanger Institute.
Dr. Bradley was Professor at Baylor College of Medicine.
Dr. Bradley completed undergraduate, graduate, and doctorate degrees at the University of Cambridge.

Cargos activos de Alan Bradley

EmpresasCargoInicio
Director/Miembro de la Junta -
Fundador -
Corporate Officer/Principal -

Antiguos cargos conocidos de Alan Bradley.

EmpresasCargoFin
Fundador -
Corporate Officer/Principal -
LEXICON PHARMACEUTICALS, INC. Fundador -
Director/Miembro de la Junta -
Fundador -
Ver el detalle de la experiencia de Alan Bradley.

Formación de Alan Bradley.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

91

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Commercial Services